Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Public ClinicalTrials.gov record NCT00020969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase Two Multicenter Study Of Arsenic Trioxide In Patients With Myelodysplastic Syndromes
Study identification
- NCT ID
- NCT00020969
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- CTI BioPharma
- Industry
- Enrollment
- Not listed
Conditions and interventions
Interventions
- arsenic trioxide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 120 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2001
- Primary completion
- Dec 31, 2004
- Completion
- Dec 31, 2004
- Last update posted
- Oct 4, 2020
2001 – 2005
United States locations
- U.S. sites
- 8
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Cancer Center at University of Arizona Health Sciences Center | Tucson | Arizona | 85724 | — |
| Green Cancer Center at Scripps Clinic | La Jolla | California | 92037-1027 | — |
| USC/Norris Comprehensive Cancer Center and Hospital | Los Angeles | California | 90033-0804 | — |
| Jonsson Comprehensive Cancer Center, UCLA | Los Angeles | California | 90095-1678 | — |
| St. Joseph Hospital Regional Cancer Center - Orange | Orange | California | 92868-3849 | — |
| Lynn Regional Cancer Center West | Boca Raton | Florida | 33428 | — |
| Georgia Cancer Specialists - Northside Office | Atlanta | Georgia | 30342 | — |
| Corpus Christi Cancer Center | Corpus Christi | Texas | 78412 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00020969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 4, 2020 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00020969 live on ClinicalTrials.gov.